Thursday, February 28, 2013

Groups to Ala. Supreme Court: Reconsider generic-drugs decision

Groups to Ala. Supreme Court: Reconsider generic-drugs decision
Business groups led by the U.S. Chamber of Commerce and the Pharmaceutical Research and Manufacturers of America are pressing the Alabama Supreme Court to reconsider its ruling that makes brand-name drugmakers liable for injuries caused by generic versions of their treatments. "By essentially absolving [generic-drug-makers] of any responsibility, you're saying they don't have to perform that job very carefully," PhRMA General Counsel Mit Spears said. In a separate court brief, the Chamber of Commerce said the decision "threatens to unleash the plaintiffs' bar on all manufacturers doing business in Alabama" and "eviscerates basic tort limitations." The Wall Street Journal(2/24) LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Update account information |Change e-mail address |Unsubscribe |Print friendly format |Web version |Search past news |Archive |Privacy policy

Account Director, Life Sciences: Meryl Harold (202) 407-7828
Read more
Recent DIA Global SmartBrief Issues: Lead Editor: Lisa Gough

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2013 SmartBrief, Inc.® Legal Information

No comments:

Post a Comment